KR100541719B1 - A raw-food composition improved the digestion and antioxidation - Google Patents
A raw-food composition improved the digestion and antioxidation Download PDFInfo
- Publication number
- KR100541719B1 KR100541719B1 KR1020030054522A KR20030054522A KR100541719B1 KR 100541719 B1 KR100541719 B1 KR 100541719B1 KR 1020030054522 A KR1020030054522 A KR 1020030054522A KR 20030054522 A KR20030054522 A KR 20030054522A KR 100541719 B1 KR100541719 B1 KR 100541719B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- food
- seaweed
- enzymes
- reproductive
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 230000029087 digestion Effects 0.000 title abstract description 9
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 59
- 108090000790 Enzymes Proteins 0.000 claims abstract description 59
- 229940088598 enzyme Drugs 0.000 claims abstract description 59
- 235000013305 food Nutrition 0.000 claims abstract description 55
- 230000001850 reproductive effect Effects 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 25
- 230000006870 function Effects 0.000 claims abstract description 24
- 239000004365 Protease Substances 0.000 claims abstract description 23
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 22
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 19
- 241001474374 Blennius Species 0.000 claims abstract description 15
- 108091005804 Peptidases Proteins 0.000 claims abstract description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 15
- 235000013311 vegetables Nutrition 0.000 claims abstract description 15
- 241000239366 Euphausiacea Species 0.000 claims abstract description 13
- 230000001079 digestive effect Effects 0.000 claims abstract description 13
- 235000013339 cereals Nutrition 0.000 claims abstract description 11
- 108010059892 Cellulase Proteins 0.000 claims abstract description 10
- 241000238557 Decapoda Species 0.000 claims abstract description 10
- 102000004882 Lipase Human genes 0.000 claims abstract description 10
- 108090001060 Lipase Proteins 0.000 claims abstract description 10
- 239000004367 Lipase Substances 0.000 claims abstract description 10
- 229940106157 cellulase Drugs 0.000 claims abstract description 10
- 235000019421 lipase Nutrition 0.000 claims abstract description 10
- 229940040461 lipase Drugs 0.000 claims abstract description 10
- 102100026189 Beta-galactosidase Human genes 0.000 claims abstract description 9
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims abstract description 9
- 102100022624 Glucoamylase Human genes 0.000 claims abstract description 9
- 108010059881 Lactase Proteins 0.000 claims abstract description 9
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims abstract description 9
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 9
- 239000001573 invertase Substances 0.000 claims abstract description 9
- 235000011073 invertase Nutrition 0.000 claims abstract description 9
- 229940116108 lactase Drugs 0.000 claims abstract description 9
- 239000004382 Amylase Substances 0.000 claims abstract description 8
- 108010065511 Amylases Proteins 0.000 claims abstract description 8
- 102000013142 Amylases Human genes 0.000 claims abstract description 8
- 235000019418 amylase Nutrition 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 235000021329 brown rice Nutrition 0.000 claims description 6
- 241001107116 Castanospermum australe Species 0.000 claims description 5
- 235000021279 black bean Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 240000005528 Arctium lappa Species 0.000 claims description 3
- 235000003130 Arctium lappa Nutrition 0.000 claims description 3
- 235000008078 Arctium minus Nutrition 0.000 claims description 3
- 240000002900 Arthrospira platensis Species 0.000 claims description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 3
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 3
- 235000000832 Ayote Nutrition 0.000 claims description 3
- 240000004244 Cucurbita moschata Species 0.000 claims description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 3
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 244000000231 Sesamum indicum Species 0.000 claims description 3
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 3
- 229940094952 green tea extract Drugs 0.000 claims description 3
- 235000020688 green tea extract Nutrition 0.000 claims description 3
- 235000015136 pumpkin Nutrition 0.000 claims description 3
- 229940082787 spirulina Drugs 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 229940109529 pomegranate extract Drugs 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 244000088415 Raphanus sativus Species 0.000 claims 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 1
- 235000019419 proteases Nutrition 0.000 abstract description 13
- 108010004032 Bromelains Proteins 0.000 abstract description 4
- 108090000526 Papain Proteins 0.000 abstract description 4
- 235000019835 bromelain Nutrition 0.000 abstract description 4
- 235000019834 papain Nutrition 0.000 abstract description 4
- 229940055729 papain Drugs 0.000 abstract description 4
- 230000003871 intestinal function Effects 0.000 abstract description 2
- 230000033458 reproduction Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 240000004371 Panax ginseng Species 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- 229930182490 saponin Natural products 0.000 description 9
- 150000007949 saponins Chemical class 0.000 description 9
- 235000017709 saponins Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000002789 Panax ginseng Nutrition 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 102000007330 LDL Lipoproteins Human genes 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 5
- -1 anti-inflammatory Chemical class 0.000 description 5
- 229940118019 malondialdehyde Drugs 0.000 description 5
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 235000013793 astaxanthin Nutrition 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 2
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000479753 Aspergillus niger ATCC 1015 Species 0.000 description 1
- 241000238017 Astacoidea Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 241000238562 Farfantepenaeus aztecus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 150000001514 astaxanthins Chemical class 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
본 발명은 곡물류, 야채류 또는 해조류 건조분말에 식품효소 혼합물, 발효콩 파우더 및 크릴새우 엑스를 혼합하여 소화기능과 항산화기능을 증진시키는 생식조성물에 관한 것으로 좀더 상세히는 아밀라제, 프로테아제, 리파아제, 셀룰라제, 락타제, 글루코아밀라제, 맥아 다이아스타제, 인버타제, 파파인 또는 브로멜라인 등의 식품효소 혼합물과 발효콩 파우더, 크릴새우 엑스 등을 곡물류, 야채류 또는 해조류 등의 건조분말과 혼합하여 소화기능 및 항산화기능을 증진시키고 장기능을 활성시키는 생식조성물에 관한 것이다.The present invention relates to a reproductive composition which enhances digestion and antioxidant function by mixing food enzyme mixture, fermented soybean powder and krill shrimp with dry grains, vegetables or seaweed dry powder. More specifically, amylase, protease, lipase, cellulase, Digestive and antioxidant properties by mixing a mixture of food enzymes such as lactase, glucoamylase, malt diasterase, invertase, papain or bromelain, and fermented soybean powder and krill shrimp with dry powder such as cereals, vegetables or seaweed It relates to a reproductive composition that promotes function and activates intestinal function.
생식, 소화기능, 항산화기능, 발효콩, 식품효소, 크릴새우Reproduction, digestion, antioxidant, fermented soybean, food enzyme, krill
Description
도 1은 본 발명의 일실시예로 식품효소 혼합물로 "뉴트라자임"을 사용하여 생식조성물을 제조하는 공정도를 도식화한 것이다.Figure 1 is a diagram illustrating a process for preparing a reproductive composition using "nutrazyme" as a food enzyme mixture in one embodiment of the present invention.
본 발명은 곡물류, 야채류 또는 해조류 건조분말에 식품효소 혼합물, 발효콩 파우더 및 크릴새우 엑스를 혼합하여 소화기능과 항산화기능을 증진시키는 생식조성물에 관한 것으로 좀더 상세히는 아밀라제, 프로테아제, 리파아제, 셀룰라제, 락타제, 글루코아밀라제, 맥아 다이아스타제, 인버타제, 파파인 또는 브로멜라인 등의 식품효소 혼합물과 발효콩 파우더, 크릴새우 엑스 등을 곡물류, 야채류 또는 해조류 등의 건조분말과 혼합하여 소화기능 및 항산화기능을 증진시키고 장기능을 활성시키는 생식조성물에 관한 것이다.The present invention relates to a reproductive composition which enhances digestion and antioxidant function by mixing food enzyme mixture, fermented soybean powder and krill shrimp with dry grains, vegetables or seaweed dry powder. More specifically, amylase, protease, lipase, cellulase, Digestive and antioxidant properties by mixing a mixture of food enzymes such as lactase, glucoamylase, malt diasterase, invertase, papain or bromelain, and fermented soybean powder and krill shrimp with dry powder such as cereals, vegetables or seaweed It relates to a reproductive composition that promotes function and activates intestinal function.
현대사회가 직면하고 있는 여러 가지 문제들 가운데 건강에 관한 문제만큼 우리의 관심을 끄는 것도 없을 것이다. 그 동안 많은 사람들에게 상식화되어 있었고 아무런 문제없이 즐겨왔던 화식(火食)과 서양식의 음식들이 암을 비롯한 다양한 질환을 야기할 수 있는 것으로 알려지고 있다. 현재 우리가 섭취하고 있는 음식, 특히 가공식품이 많이 잘못되어 있으며 이러한 잘못을 수정하기 위해 좀 더 개선된 음식(특히 채식을 위주로 한 식단)을 섭취하는 것이 바람직하다는 것이다. Among the problems facing modern society, nothing will draw our attention to health. It has been known that many of the common foods that have been common sense for many people and enjoyed without any problems are food and western foods that can cause various diseases including cancer. Many of the foods we eat now, especially processed foods, are wrong, and it is advisable to eat more advanced foods (especially vegetarian diets) to correct them.
음식의 종류를 그 뜻을 구분하기 위해 넓게 분류하면 생식(生食), 화식(火食), 선식(仙食), 자연식(自然食), 생채식(生菜食) 등으로 분류할 수 있다. 생식이라 함은 추출하거나 열에 익히지 않은 자연 그대로의 음식들로서 곡류, 야채, 과일, 생고기 등을 가리키며 이와 대비되는 화식이라 함은 일반적으로 가정이나 식당에서 열을 이용한 조리과정을 통해 섭취되는 모든 식품을 가리킨다. 일상적인 가게에서 판매 유통되는 모든 가공식품은 화식의 범주로 이해하면 된다. 선식은 옛 스님들이 잡곡을 쪄서 말리고 볶은 후 가루로 빻아 물에 개어 죽처럼 먹던 것을 일컬으며 자연식은 특별한 가공 없이 자연원료를 이용한 음식을 말한다. 생채식은 생식에 속하나 주로 채소나 열매 위주의 식사를 하는 것을 칭하기도 한다. 이 중에서 특히 생식은 최근 문제가 되는 성인병을 예방하고 영양섭취도의 차이에 따라(표 1) 여러 질병발생율을 최고 10배까지 줄여준다는 연구결과에 힘입어 그 시장이 크게 성장하고 있다(표 2).If the food is broadly classified to distinguish its meaning, it can be classified into raw food, raw food, fire food, natural food, and natural food. Raw food refers to natural foods that are not extracted or cooked, and refers to cereals, vegetables, fruits, and raw meats. In contrast, flowering means generally all foods consumed by cooking using heat in homes or restaurants. . All processed foods sold and sold in everyday shops can be understood as categories of flowering. Sunsik refers to the old monks who used to dry grains, roast them, grind them, grind them into powder and eat them like porridge. Natural foods are foods made from natural raw materials without any special processing. Raw vegetables are raw foods, but they are often eaten mainly with vegetables or fruits. In particular, the market is growing significantly thanks to research that reproductive disease prevents adult diseases, which is a problem recently, and reduces the incidence of various diseases by up to 10 times according to the difference in nutritional intake (Table 1). .
국내 전체 건강식품 관련 시장의 연평균 성장률이 23%인 반면 생식시장의 연평균 성장률은 56%로 관련 업계 성장률의 2배 이상을 기록하는 폭발적인 잠재력을 가진 시장이라 할 수 있다. 500명을 대상으로 생식을 섭취하는 나이 분포를 살펴보면 40대 이상이 전체의 67%를 차지하며(표 3) 생식을 먹는 이유로는 질병회복과 다이어트를 고려한 대용식으로 복용하는 것으로 나타났다(표 4). 따라서 생식은 질병의 예방 및 치유에 도움을 줄 수 있는 기능성과 식사로서의 맛이 중요한 요인임을 알 수 있다.The annual average growth rate of the entire health food-related market in Korea is 23%, while the reproductive market has an annual growth rate of 56%, more than twice the growth rate of the related industry. Looking at the age distribution of raw foods for 500 people, more than 40 years of age accounted for 67% of the total (Table 3). The reason for eating raw foods was taken as a substitute for disease recovery and diet (Table 4). Therefore, it can be seen that reproduction is an important factor in the functionality that can help prevent and cure disease and taste as a meal.
최근 이러한 시장의 증가에 따라 많은 업체가 생식을 제조 판매하고 있으며 그 과정에서 생식의 본래의 취지에 어긋난 제품이 시장에 난립하고 있는 상황이다. 최근의 설문조사에 따르면 생식을 복용함에 있어서 개선이 요구되는 사항으로 난소화성을 꼽는 경우가 무척 많다(개별 면담 결과). 생식의 정의대로 열에 익히지 않은 자연 그대로의 상태로 가공하는 것이 현실적으로 불가능한 면이 많고 이에 따라 생식에 반드시 존재해야 할 효소, 항산화성분, 영양소가 파괴되는 것이 현실이다. 따라서 생식의 섭취를 통하여 얻고자 하는 소비자의 만족을 극대화시키기 위해서는 생식의 가공과정에서 발생하는 이 문제점을 보완하기 위하여 추가적인 성분의 보완이 필수적이다.With the recent increase in the market, many companies manufacture and sell raw food, and in the process, there is a situation in which a product which is not inherent in the raw food is in the market. According to recent surveys, there are many cases where ovary is considered to be an improvement in taking reproduction (individual interview results). As the definition of reproduction, it is impossible to process it in its natural state without heat, and the reality is that the enzymes, antioxidants, and nutrients that must be present in reproduction are destroyed. Therefore, in order to maximize the consumer's satisfaction through the ingestion of raw foods, supplementation of additional ingredients is essential to compensate for this problem that occurs during the processing of raw foods.
첫째로 보강해야할 성분인 효소에 대해 알아본다. 효소(enzyme)란 체내에서 발생하는 모든 생명활동 반응에서 촉매 작용을 하는 단백질로서, 음식물의 소화 및 인체 생명유지에 가장 중요한 역할을 담당한다. 효소의 종류는 크게 식품효소, 대사효소, 소화효소로 나눌 수 있다. 이중 식품효소는 단백질, 지방, 탄수화물 등 음식물을 분해하는 작용을 하며 그 종류는 약 22가지인데, 가장 중요한 효소들은 대개 췌장에서 만들어진다. 만약 췌장에서 효소들이 충분히 생성되지 못하면 영양소 흡수가 불가능해지며, 이런 경우에는 외부에서 효소를 추가로 투여해야 한다. 이때 투여 가능한 효소로는 췌장효소와 식물성효소 두 가지로서, 식물성 효소는 소화기 계통의 기능을, 췌장 효소는 소화기능과 면역기능 두 가지를 모두 강화하는 작용을 한다. 이 작용을 하는 소화효소에는 프로테아제(protease), 아밀라제(amylase), 리파제(lipase), 셀룰라제(cellullase), 펙티나제(pectinase), 락타제(lactase), 카뎁신(cathepsin), 항산화효소(antioxidant enzyme), 브로멜라인(bromelain), 파파인(papain), 글루코아밀라제(glucoamylase), 인버타제(invertase), 카탈라제(catalase) 등이 있다. 효소는 우리 몸이 섭취하는 다양한 음식물을 영양소로 분해하고 흡수되는 것을 도와, 우리 몸의 각종 대사작용 속도를 정상적으로 만들어주는 물질이다. 따라서 효소가 인체내의 생화학반응을 진행시키는 속도는 효소가 존재하지 않을 때보다 수억 배 빠르다. 사람이 나이를 먹게 되면 몸 안에서 만들어지는 효소의 양이 감소되는데 노인들이 젊은 사람들에 비해 소화를 못 시키는 이유도 이 때문이다. 효소를 섭취해야 하는 이유는 우리 몸에 효소가 부족하면 여러 가지 증상이 발생하기 때문이다. 특히 식품효소의 부족은 여러 증상을 나타내는데, 프로테아제(protease)가 부족하면 불안감, 수족냉증, 면역기능 약화, 신장기능 약화, 칼슘 흡수 부족, 혈전생성 등의 증상이 발생하기 쉽다. 아밀라제가 부족 하면 소화장애, 입술염증, 벌레알러지, 근육통 등이 증상이 발생하기 쉽고 리파제가 부족하면 위장기능 장애, 담석, 고지혈증, 심혈관 질환, 당뇨, 어지럼증 등의 증상이 발생하기 쉽다. 2당분해효소(disaccharidase)가 부족하면 설사, 변비, 불면증, 우울증 등의 증상이 발행하기 쉽고 셀룰라제가 부족하면 복부팽만감, 가스참, 세균감염, 안면통증 등의 증상이 발생하기 쉽다. 따라서 잘 보강된 모든 식품효소가 균형 있게 첨가된 안전한 효소혼합물은 생식과 결합되어 최고의 기능을 나타낼 것이다.First, learn about enzymes that need to be enriched. Enzymes are proteins that catalyze all vital reactions in the body and play the most important role in the digestion of food and the maintenance of human life. Types of enzymes can be largely divided into food enzymes, metabolism enzymes, digestive enzymes. Food enzymes are responsible for breaking down foods such as proteins, fats, and carbohydrates. About 22 kinds of food enzymes, the most important enzymes are usually made in the pancreas. If enough enzymes are not produced in the pancreas, nutrient absorption will be impossible, in which case additional enzymes must be administered externally. At this time, the enzymes that can be administered are pancreatic enzymes and vegetable enzymes. The plant enzymes function in the digestive system, and the pancreatic enzymes function to enhance both digestive and immune functions. Digestive enzymes that act include protease, amylase, lipase, cellulase, pectinase, lactase, cathepsin, and antioxidant enzymes. antioxidant enzyme, bromelain, papain, glucoamylase, invertase, catalase, and the like. Enzymes are substances that help our body break down and absorb various foods into nutrients and make our body's metabolic rate normally. Thus, the rate at which enzymes progress biochemical reactions in humans is hundreds of millions of times faster than without enzymes. As people age, the amount of enzymes produced in the body decreases, which is why older people are less able to digest than younger people. The reason why you need to take enzymes is because a lack of enzymes in our body causes a variety of symptoms. In particular, the lack of food enzymes show a number of symptoms, the lack of protease (protease), such as anxiety, cold hands and feet, weakened immune function, kidney function weakness, lack of calcium absorption, blood clots are likely to occur. Lack of amylase can cause symptoms such as digestive disorders, lip inflammation, bug allergies, and muscle pain. Lack of lipase can lead to gastrointestinal dysfunction, gallstones, hyperlipidemia, cardiovascular disease, diabetes, and dizziness. The lack of diaccharidase is a symptom of diarrhea, constipation, insomnia, and depression, and the lack of cellulase is likely to cause bloating, gas cramps, bacterial infections, and facial pain. Thus, a safe enzyme mixture with all well-enriched food enzymes in balance will combine with reproductive function to achieve the best function.
일반적으로 식품효소가 나타내는 치유능을 정리하면 다음과 같다.In general, the healing powers represented by food enzymes are as follows.
① 체내 환경정비 ① Environmental maintenance
식품 효소는 혈액을 약알칼리로 만들고 체내의 이물질을 제거시켜 주며 장내 세균의 밸런스를 유지시켜 준다. 또한 소화를 촉진시키고 병원균에 대한 저항력을 유지시켜 준다.Food enzymes make the blood weakly alkaline, remove foreign substances from the body, and balance the intestinal bacteria. It also promotes digestion and maintains resistance to pathogens.
② 항염증 작용 ② anti-inflammatory action
일반 의약품은 대개가 항생제로서 병원균을 죽이는 역할을 하므로 이 작용만으로는 세포를 새로 만드는 일을 할 수 없다. 효소는 백혈구를 운반하고, 백혈구의 활동을 도와 병원균을 죽이고, 상처 입은 세포를 재생시키는데 도움을 주며 염증을 가라앉혀 준다. Generic drugs usually kill the pathogen as an antibiotic, so this action alone does not allow you to create new cells. Enzymes carry white blood cells, help white blood cells to kill pathogens, regenerate wounded cells, and calm inflammation.
③ 항균 작용 ③ antibacterial effect
효소는 백혈구의 식균작용을 돕는 동시에, 효소 자체에도 항균작용이 있어 병원균을 죽인다. 더욱이 세포의 생성을 촉진하는 작용을 하기 때문에 병을 근본적 으로 치료할 수 있다.Enzymes help the phagocytosis of white blood cells, while also killing pathogens because they have antibacterial activity. Moreover, the disease can be fundamentally treated because it acts to promote the production of cells.
④ 분해 작용 ④ decomposition
효소는 병이 생긴 장소의 혈관 내에 고름이나 독소들을 분해하고 배설시켜 정상적인 상태로 돌려놓는 작용을 한다. 이 작용은 섭취한 음식물을 소화시키기 위해 음식물을 분해하는 것과 일맥 상통하는 것이다. Enzymes break down and excrete pus or toxins in the blood vessels where the disease occurs and return them to normal. This action is in line with the breakdown of food to digest the food you eat.
⑤ 혈액 정화 작용 ⑤ blood purification
효소는 혈액 중의 노폐물을 몸 바깥으로 내보내고, 또 염증 등의 독성을 분해하여 배출시키는 작용을 한다. 이외에도 산성화된 혈액에 대해서는 혈액 중의 콜레스테롤을 분해하여 약알칼리로 유지시키는 활동과, 혈액의 흐름을 원활하게 해주는 역할을 한다. 이러한 혈액의 정화로 혈액의 순환이 잘되어 대머리가 치료되고 어깨 결림, 펜타성 두통 등이 치료된 사례가 보고되었다. Enzymes release waste products in the blood to the outside of the body, and also function to decompose and release toxicities such as inflammation. In addition to the acidified blood to decompose cholesterol in the blood activity to maintain weak alkali, and serves to smooth the flow of blood. This blood purification has been reported to treat the baldness, stiff shoulder, penta headache, etc. due to the good circulation of the blood.
⑥ 세포 부활 작용 ⑥ cell activation
효소는 세포의 신진대사를 도와주어 기본적인 체력을 유지시키고, 상처받은 세포의 생성을 도와준다. 효소가 모든 세포의 활동에 촉매작용을 할 때는 하나 하나가 분산적으로 이루어지는 것이 아니라 전체 효소가 일제히 작용을 한다. 따라서 일반 약품의 효능과는 다른 신체의 근본적인 치료를 담당할 수 있다. Enzymes help the cells metabolize, maintain basic stamina, and help the production of wounded cells. When enzymes catalyze the activity of all cells, not all of them are dispersed, but all enzymes work in unison. Therefore, it is possible to take charge of the fundamental treatment of the body different from the efficacy of general medicine.
효소를 생식에 적용한 예로는 "콜레스테롤 및 혈전 저하기능이 강화된 생식 타입의 차 조성물(대한민국 특허공보 제2001-074008호)"이 있으며, 상기 발명은 콜레스테롤 생합성을 억제하는 홍국과 혈전 용해기능이 있는 효소인 나토키나제를 첨가하여 혈액순환 장해 개선효과를 강화한 생식 타입 차 조성물에 관한 것이다. Examples of application of the enzyme to reproduction include "reproductive type tea composition with enhanced cholesterol and thrombus lowering function (Korean Patent Publication No. 2001-074008)", and the present invention has a red blood cell that inhibits cholesterol biosynthesis and a thrombolytic function. The present invention relates to a reproductive type tea composition in which an enzyme, nattokinase, is added to enhance blood circulation disorders.
본 발명의 목적은 기존 생식제품의 단점인 난소화성을 해결하고 생식의 영양요구성을 1회 식사로 가능하게 하며 섭취 시 인체 내 항산화능을 증가시켜 질병을 억제하고 노화를 방지시키는 것이다.
An object of the present invention is to solve the disadvantages of the existing reproductive products and to digest the nutritional composition of the reproductive diet with a single meal and to increase the antioxidant capacity in the human body when ingested to inhibit diseases and prevent aging.
상기 목적을 달성하기 위하여, 본 발명은 해조류, 야채류 또는 곡물류의 건조분말이 다시마 1~5중량%, 김 1~5 중량%, 미역 1~5중량%, 현미 5~20중량%, 발아현미 5~20중량%, 검은콩 5~20중량%, 스피루리나 1~10중량%, 메밀 0.2~1중량%, 율무 0.2~1중량%, 옥수수 0.2~1중량%, 호박 0.2~1중량%, 우엉 0.2~1중량%, 연근 0.2~1중량%, 표고버섯 0.2~1중량%, 솔잎 0.1~0.8중량%, 구기자 0.1~0.8중량%, 신선초 0.1~0.8중량%, 깨 0.1~0.8중량%, 함초 0.1~0.8중량%, 올리고당 0.1~0.8중량% 및 자일리톨 0.1~0.8중량%로 구성된 곡물류, 야채류 또는 해조류의 건조분말에 In order to achieve the above object, the present invention is a dried powder of seaweed, vegetables or grains kelp 1-5% by weight, laver 1-5% by weight, seaweed 1-5% by weight, brown rice 5-20% by weight, germinated brown rice 5 ~ 20% by weight, black beans 5-20%, spirulina 1-10%, buckwheat 0.2-1%, barley 0.2-1%, corn 0.2-1%, pumpkin 0.2-1%, burdock 0.2 ~ 1 wt%, lotus root 0.2-1 wt%, shiitake mushroom 0.2-1 wt%, pine needles 0.1-0.8 wt%, wolfberry 0.1-0.8 wt%, fresh vinegar 0.1-0.8 wt%, sesame 0.1-0.8 wt%, seaweed 0.1 Dry powder of cereals, vegetables or algae consisting of ~ 0.8% by weight, 0.1-0.8% by weight oligosaccharide and 0.1-0.8% by weight of xylitol
아밀라제, 인버타제, 맥아 다이아타제, 리파제, 프로테아제 SAP, 프로테아제 HUT, 글루코아밀라제, 셀룰라제 또는 락타제로 구성된 그룹 중에서 선택된 2종 이상의 식품효소 혼합물을 건조분말 100중량%에 대하여 0.1~2중량%, 발효콩 파우더 5~20%, 크릴새우 엑스 0.1~2중량%를 혼합하여 제조됨을 특징으로 하는 소화기능 및 항산화기능이 강화된 생식조성물에 관한 것이다. 상기 생식조성물 중 해조류, 야채류 또는 곡물류의 건조분말은 기존의 생식조성물에 있어서 영양성분과 향미 등을 고려하여 결정되었다.0.1-2% by weight based on 100% by weight of dry powder, a mixture of two or more food enzymes selected from the group consisting of amylase, invertase, malt diatase, lipase, protease SAP, protease HUT, glucoamylase, cellulase or lactase It relates to a reproductive composition with enhanced digestive and antioxidant functions, which is prepared by mixing 5-20% soybean powder and 0.1-2% by weight of krill shrimp. The dry powder of the seaweeds, vegetables or grains of the reproductive composition was determined in consideration of the nutritional component and flavor in the existing reproductive composition.
또한, 본 발명은 상기 생식조성물의 항산화기능을 강화시키기 위하여 녹차추출물 5~20중량%, 석류추출물 5~20중량%, 트레할로스 1~10중량% 또는 비타민 C 1~5중량% 중 1종 이상을 부가하는 것을 특징으로 하는 소화기능 및 항산화기능이 강화된 생식조성물에 관한 것이다.In addition, the present invention in order to enhance the antioxidant function of the reproductive composition of green tea extract 5-20% by weight, pomegranate extract 5-20% by weight, trehalose 1-10% by weight or vitamin C 1-5% by weight of one or more It relates to a reproductive composition with enhanced digestive and antioxidant functions, characterized in that the addition.
또한, 본 발명은 상기 생식조성물이 홍삼 0.1~2중량% 또는 유산균 0.3~0.6중량%를 부가, 혼합하는 것을 특징으로 하는 소화기능 및 항산화기능이 강화된 생식조성물에 관한 것이다. The present invention also relates to a reproductive composition with enhanced digestive and antioxidant functions, characterized in that the reproductive composition is added and mixed with red ginseng 0.1-2% by weight or 0.3-0.6% by weight of lactic acid bacteria.
상기 식품효소, 발효콩 파우더, 크릴새우 엑스 및 홍삼과 유산균의 함량은 생식조성물의 영양과 관능검사에 따른 결과를 토대로 하여 정한 것이다.The content of the food enzymes, fermented soybean powder, krill shrimp X and red ginseng and lactic acid bacteria is determined based on the results of nutritional and sensory test of the reproductive composition.
본 발명의 항산화성 증진을 위해 사용한 크릴새우는 북극의 청정 해역에서 서식하는 붉은 색의 새우로서 아스타잔틴(astaxanthin)이란 항산화성분이 포함되어 있다. 아스타잔틴은 카로티노이드계 물질로서 비타민A의 전구체이며 새우, 가재 등의 갑각류뿐만 아니라 송어, 연어 등의 어류에도 다량 함유되어 있다. 아스타잔틴의 항산화활성은 활성산소를 불활성화시킴으로서 이루어지며 일반적으로 알려진 항산화물질인 베타카로틴의 10배, 토코페롤의 500배, 비타민E의 1,000배의 항산화활성을 가진다. 이외에도 암세포의 기형적인 세포분화를 억제하는 항암작용이 보고되 어 있으며 항체 형성을 촉진하여 인체 면역기능 강화에도 일익을 담당한다. Krill shrimp used to enhance the antioxidant properties of the present invention is a red shrimp inhabiting the clean waters of the Arctic, astaxanthin (antiaxanthin) contains an antioxidant component. Astaxanthin is a carotenoid-based substance, a precursor of vitamin A, and is contained in fish, such as trout and salmon, as well as shellfish such as shrimp and crayfish. Astaxanthin's antioxidant activity is achieved by inactivating free radicals and has 10 times the known antioxidants beta-carotene, 500 times the tocopherol, and 1,000 times the vitamin E. In addition, it has been reported that anti-cancer activity that inhibits the abnormal cell differentiation of cancer cells, and plays an important role in enhancing the immune function of the human body by promoting the formation of antibodies.
크릴새우에는 이 아스타잔틴 이외에도 혈액순환을 개선하고 노화를 방지하는 많은 성분인 오메가-3 오일과 천연 비타민, 아미노산 등이 포함되어 있는데 그 성분은 아래 표 5와 같다.In addition to this astaxanthin, krill contains many ingredients such as omega-3 oils, natural vitamins and amino acids, which improve blood circulation and prevent aging.
본 발명에는 크릴새우와 더불어 다양한 약리활성을 지닌 인삼사포닌이 풍부 한 홍삼분말이 사용되었다. 인삼의 가장 중요한 성분은 인삼사포닌으로서 현재까지 고려인삼 속 식물종에서 분리 보고된 사포닌은 60여종 이상이며 고려인삼에서 확인된 사포닌은 30여종에 이른다. 사포닌은 화학적으로는 배당체의 일종으로서 거품을 내는 특성이 있으며 750여종의 식물에 광범위하게 분포되어 있다. 사포닌을 함유하는 식물들은 예전부터 세정, 거담, 진해의 치유를 위한 의약에 사용되어 왔으며 최근에는 소염, 건위, 항종양, 이뇨, 강장 및 강정 등 사포닌의 특이적인 약효가 확인되고 있다. 고려인삼은 PPD(protopanaxadiol)계와 PPT(protopanaxatriol)계의 조성비율이 균등하며 또한 항암활성 성분인 진세노사이드 Rh2와 통증억제 작용을 하는 진세노사이드 Rf는 미국 삼에는 없는 것으로 확인되고 있다. 한편 홍삼과 백삼에 공통적으로 함유되어 있는 사포닌은 19종이며 홍삼과 백삼의 특유 사포닌은 홍삼에 9종 그리고 백삼에 4종이 있는 데 이는 가공방법의 차이에 따르는 결과로 고려된다.In the present invention, red ginseng powder rich in krill and ginseng saponin having various pharmacological activities was used. The most important component of ginseng is ginseng saponin. To date, more than 60 types of saponins reported from Korean ginseng plant species have been reported, and about 30 kinds of saponins identified from Korean ginseng. Saponins are chemically a form of glycosides that foam and are widely distributed in over 750 plants. Plants containing saponins have been used in medicine for the healing of scavenging, expectoration and antitussives, and recently, the specific effects of saponins such as anti-inflammatory, healthy stomach, anti-tumor, diuresis, tonic and gangjeong have been confirmed. Korean ginseng has the same composition ratio of PPD (protopanaxadiol) and PPT (protopanaxatriol) system, and it is confirmed that ginsenoside Rh 2 , an anticancer active ingredient, and ginsenoside R f , a pain inhibitory agent, do not exist in US ginseng. . On the other hand, there are 19 kinds of saponins which are commonly contained in red and white ginseng, and 9 kinds of saponins unique to red and white ginseng are four in red ginseng and four in white ginseng.
또한, 본 발명은 장운동을 활성화시키기 위하여 콩을 사용하였다. 콩은 예로부터 양질의 단백질 공급원일 뿐만 아니라 원활한 장운동을 돕는 작용을 하는 것으로 잘 알려져 있다. 본 발명에서는 국산 검은콩뿐만 아니라 미생물 발효를 통해 소화흡수율을 높인 발효콩을 첨가하여 장운동을 돕고 소화흡수를 용이하게 하였다. 콩 이외의 정장작용을 가지는 물질로 유산균과 올리고당이 대표적인데, 본 발명에서는 이 두 물질도 첨가하여 정장기능을 극대화시켰다. 발효콩을 이용한 건강식품의 용례는 무척 다양하나 최근 납두균을 이용한 무취 발효콩을 제조하는(대한미국 특허공보 제2001-0069777호) 것이 대표적인 선행기술로 알려져 있다. 이외에 누에 고치를 산가수분해시킨 저분자 펩타이드를 소재로 한 소화기능성 생식 제조기술(대한민국 특허공보 제2000-007053호)이 알려져 있다. 단백질의 단량체인 아미노산의 함량을 높인 제품으로서 영양균형을 잘 조절한 것이 특징이다. 그러나 아미노산의 소재가 식물성이 아닌 동물성 누에이므로 식물성 생식의 취지에는 부합하지 않는 기술이다. 이에 반해 본 발명에서는 유산균과 납두균을 이용하여 콩을 발효하고 이 콩을 생식의 소재로 이용하여 전체적으로 소화기능을 증대시키는 목적으로 사용되었다.In addition, the present invention used soybeans to activate the bowel movement. Beans have long been known to be a good source of protein as well as to help smooth bowel movement. In the present invention, the addition of fermented soybeans to increase the digestion absorption rate through microbial fermentation as well as domestic black beans to help the bowel movement and facilitate digestion and absorption. Lactobacillus and oligosaccharides are typical as a substance having a formal action other than soybean, and in the present invention, these two substances were also added to maximize the formal function. Applications of health foods using fermented soybeans are very diverse, but recently, manufacturing odorless fermented soybeans using Naphtha bacteria (Korean Patent Publication No. 2001-0069777) is known as a representative prior art. In addition, a technique for producing a digestive functional reproductive system based on a low molecular weight peptide obtained by acid hydrolysis of cocoon (Korean Patent Publication No. 2000-007053) is known. It is a product with high content of amino acid which is a monomer of protein, and it is characterized by well-controlled nutritional balance. However, since the material of amino acids is animal silkworm, not vegetable, it does not meet the purpose of vegetable reproduction. In contrast, the present invention was used for the purpose of fermenting soybeans using lactic acid bacteria and naphtha bacteria and using the soybeans as a raw material to increase digestion.
이하, 실시예를 통하여 본 발명의 구체적인 구성에 대하여 상세히 설명한다. 그러나, 본 발명의 권리범위는 이들 실시예의 기재에만 한정되는 것은 아니다.Hereinafter, the specific configuration of the present invention through the embodiment will be described in detail. However, the scope of the present invention is not limited only to the description of these examples.
실시예 1: 식품효소 혼합물 제조Example 1 Preparation of Food Enzyme Mixtures
본 실시예는 맥아에 접종한 식용미생물(GRAS)의 배양액으로부터 아밀라제, 인버타제, 맥아 다이아타제, 리파제, 셀룰라제, 락타제, 프로테아제 SAP, 프로테아제 HUT 및 글루코아밀라제를 분리, 농축한 후 안정제로 말토덱스트린을 첨가하여 식품효소 혼합물을 제조하였다. 상기 식품효소 혼합물뿐만 아니라 시판되는 "뉴트라자임(NUTRAZYME)"이라는 식품효소를 사용할 수도 있다. "뉴트라자임(NUTRAZYME)"은 상기 식품효소 혼합물에 혼합물 100중량%에 대하여 쌀눈 1중량%를 부가하여 제조된 것이다.In this embodiment, amylase, invertase, malt diatase, lipase, cellulase, lactase, protease SAP, protease HUT, and glucoamylase are separated from the culture solution of edible microorganisms (GRAS) inoculated with malt, concentrated, and maltose as a stabilizer. Dextrin was added to prepare a food enzyme mixture. In addition to the food enzyme mixture, a commercially available food enzyme called "NUTRAZYME" may be used. "NUTRAZYME" is prepared by adding 1% by weight of rice bran to 100% by weight of the mixture of food enzymes.
상기 식용미생물은 미국 균주분양협회 (ATCC, http://www.atcc.org)에서 구 입하였으며, 효소별 미생물 명칭과 번호는 다음과 같다.The edible microorganisms were purchased from the American Society for Strain Prediction (ATCC, http://www.atcc.org), and microbial names and numbers of enzymes are as follows.
아밀라제는 아스퍼질러스 오리재(Aspergillus oryzae) ATCC 1011 및 ATCC 11601을 사용하였고, 프로테아제 HUT는 아스퍼질러스 오리재(Aspergillus oryzae) ATCC 11492를 이용하였으며, 프로테아제 SAP는 아스퍼질러스 나이거(Aspergillus niger) ATCC 9029를 사용하였고, 리파아제는 리조퍼스 오리재(Rhizopus oryzae) ATCC 10260을 이용하였으며, 셀룰라제는 트리초더마 리세이(Trichoderma reesei) ATCC 56764를 사용하였고, 인버타제는 사카로마이세스 서레비지에(Saccharomyces cerevisiae) ATCC 90706을 이용하였으며, 글루코아밀라제는 아스퍼질러스 나이거(Aspergillus niger) ATCC 1015를 사용하였고, 락타아제는 아스퍼질러스 오리재(Aspergillus oryzae) ATCC 20423을 이용하였으며, 맥아 다이아스타제는 국산 보리를 사용하였다.Amylase used Aspergillus oryzae ATCC 1011 and ATCC 11601, protease HUT used Aspergillus oryzae ATCC 11492, and protease SAP was Aspergillus niger ATCC 9029 was used, and lipase was Rhizopus oryzae ATCC 10260. Cellulase was used Trichoderma reesei ATCC 56764, and Invertase was used for Saccharomyces cerevisiae. Saccharomyces cerevisiae ) ATCC 90706 was used, glucoamylase was used Aspergillus niger ATCC 1015, lactase was used Aspergillus oryzae ATCC 20423, malt diasterase was domestic Barley was used.
이 때 각 효소는 표 6에 나온 활성범위 내에서 조정한다.At this time, each enzyme is adjusted within the activity range shown in Table 6.
상기 조성물에 파파야 열매의 파파인 또는 파파야 잎 또는 파인애플 열매로부터 브로멜라인, 기타 식품용 상용 제품류를 적당량 첨가하여 생식의 단백질 분해 활성을 증대시킬 수 있다. 활성의 모든 단위는 대한민국 "식품공전"과 미국 표준 효소분석법에 명시된 방법을 따라 수행하였다.In the composition, a suitable amount of bromelain and other food products from papain or papaya leaf or pineapple fruit of papaya fruit may be added to increase the proteolytic activity of reproduction. All units of activity were performed according to the methods specified in Korean Food Code and US Standard Enzyme Assay.
실시예 2: 유산균과 발효균을 이용한 발효콩분말의 제조Example 2: Preparation of fermented soybean powder using lactic acid bacteria and fermented bacteria
선별된 국산 콩을 물로 수 차례 세척하고 10~24시간동안 물에 불리고, 물린 콩을 무르게 익힌 다음 국산 된장에서 분리한 유산균(동정 진행중)을 접종하여 48시간동안 발효하여 냄새가 없는 발효콩을 제조하였다. 제조된 콩을 감압농축기에서 24시간동안 완전건조시킨 후 분쇄기를 이용하여 분쇄하였다. 분말 형태로 가공할 경우 발효콩 분말 100g당 가미를 위해 검은콩 분말, 율무, 옥수수, 포도당, 구연산, 설탕 등을 첨가할 수 있다.Selected soybeans are washed several times with water, soaked in water for 10-24 hours, ripened with bite beans, inoculated with lactic acid bacteria (in identification) separated from domestic miso and fermented for 48 hours to produce fermented soybeans without smell. It was. The soybeans were completely dried in a vacuum condenser for 24 hours and then ground using a grinder. When processed in powder form, black beans powder, barley, corn, glucose, citric acid and sugar may be added to add 100 g of fermented soybean powder.
실시예 3: 생식조성물 제조Example 3: Preparation of Reproductive Composition
다시마 1~5중량%, 김 1~5 중량%, 미역 1~5중량%, 현미 5~20중량%, 발아현미 5~20중량%, 검은콩 5~20중량%, 스피루리나 1~10중량%, 메밀 0.2~1중량%, 율무 0.2~1중량%, 옥수수 0.2~1중량%, 호박 0.2~1중량%, 우엉 0.2~1중량%, 연근 0.2~1중량%, 표고버섯 0.2~1중량%, 솔잎 0.1~0.8중량%, 구기자 0.1~0.8중량%, 신선초 0.1~0.8중량%, 깨 0.1~0.8중량%, 녹차추출물 0.1~0.8중량%, 함초 0.1~0.8중량%, 올리고당 0.1~0.8중량% 및 자일리톨 0.1~0.8중량%의 건조분말과 실시예 1의 식품효소 혼합물 0.1~2중량%, 실시예 2의 발효콩 파우더 5~20중량%, 유산균 0.3~0.6중량%, 크릴새우 엑스 0.1~2중량% 및 홍삼 0.1~2중량%을 혼합하여 생식조성물을 제조하였다.Kelp 1-5%, seaweed 1-5%, seaweed 1-5%, brown rice 5-20%, germinated brown rice 5-20%, black beans 5-20%, spirulina 1-10% , Buckwheat 0.2-1% by weight, barley 0.2-1% by weight, corn 0.2-1% by weight, pumpkin 0.2-1% by weight, burdock 0.2-1% by weight, lotus root 0.2-1% by weight, shiitake mushroom 0.2-1% by weight , Pine needles 0.1-0.8%, wolfberry 0.1-0.8%, fresh vinegar 0.1-0.8%, sesame 0.1-0.8%, green tea extract 0.1-0.8%, seaweed 0.1-0.8%, oligosaccharides 0.1-0.8% And 0.1 to 0.8% by weight of xylitol dry powder and 0.1 to 2% by weight of the food enzyme mixture of Example 1, 5 to 20% by weight of fermented soybean powder of Example 2, 0.3 to 0.6% by weight of lactic acid bacteria, and 0.1 to 2 krill. Reproductive composition was prepared by mixing 0.1% to 2% by weight of red ginseng.
시험예 1: 소화기능 증진효과Test Example 1: Effect of enhancing digestive function
소화기능의 척도로서 제품에 포함된 식품효소의 활성을 측정하여 표 7에 나타내었다. 표 7에 나타난 바와 같이 실시예 3의 생식조성물이 국내에서 생산, 판매되는 타제품에 비해 월등히 높은 효소활성을 나타내는 것으로 나타났다.Table 7 shows the activity of food enzymes contained in the product as a measure of digestive function. As shown in Table 7, the reproductive composition of Example 3 was found to exhibit significantly higher enzymatic activity than other products produced and sold in Korea.
시험예 2: 관능검사Test Example 2: Sensory Test
20 내지 50대 남녀 각각 10명으로 구성된 전체 20여명으로 구성된 관능시험단이 생식을 섭취하고, 아래 문항에 대해 전체 20점으로 항목을 표시해 관능검사를 수행하고, 표 8에 결과를 나타내었다. 경과와 같이 본 발명의 생식 조성물이 기존의 타사 제품에 비하여 높은 점수를 받은 것을 확인할 수 있었다.A sensory test group consisting of 20 people, each composed of 10 men and women in their 20s and 50s, consumed raw food, and the sensory test was performed by marking items with a total of 20 points for the following items, and the results are shown in Table 8. As described, it was confirmed that the reproductive composition of the present invention received a high score compared to the existing third-party products.
시험예 3: 유리아미노산 측정Test Example 3: Free Amino Acid Measurement
실시예 3에서 제조된 생식조성물에 대하여 유리아미노산 함량을 측정하여 소화기능의 상대적인 정도를 확인하였다. 표 9는 국내 생식제품의 유리아미노산 정량 분석한 결과를 나타낸 것이다.The relative degree of digestive function was confirmed by measuring the content of free amino acid in the reproductive composition prepared in Example 3. Table 9 shows the results of quantitative analysis of free amino acids in Korean raw food products.
a는 시스테인이 -S-S- 결합된 것이다. a is -SS- bonded to cysteine.
* 값의 유효성 오차는 5% 범위에서 존재함. * The validity error of the value is in the range of 5%.
시험예 4: LDL의 산화 억제 효과Test Example 4 Oxidative Inhibitory Effect of LDL
대식세포의 배양액에 LDL(100㎍ protein/mL) 10㎕와 실시예 3의 생식조성물 10㎕를 각각 첨가하고 PBS(phosphate buffer saline)를 넣어 총 100㎕로 조정한 후 5% CO2 존재 하에서 20시간동안 배양하여 LDL의 산화정도를 조사하였다.The culture medium of macrophages LDL (100㎍ protein / mL) was added to the reproduction composition 10㎕ 10㎕ as in Example 3, respectively, and PBS (phosphate buffer saline) to put was adjusted to a total 100㎕ under 5% CO 2 present 20 The degree of oxidation of LDL was examined by incubating for a time.
LDL의 산화는 티오바르비튜레익산 반응성 기질(Thiobarbitureic acid reacting substances, TBARS)이 형성되는 양으로 평가하였다. LDL(100㎍ protein/mL) 10㎕가 함유된 각 농도별 배양 혼합액 100㎕에 20% TCA(Trichloroacetic acid) 1.5㎖를 가한 다음, 0.05M NaOH 2㎖와 0.67% TBA(Thiobarbituric acid)을 넣어 섞은 후 90℃에서 45분간 가열하였다. 이를 10분간 원심분리(2,000Xg)한 다음, 상등액을 Perkin-Elmer사의 형광광도계(Model 650-10S USA)로 510 및 553nm에서 측정하였다. 시료 중의 TBARS의 수는 MDA(malondialdehyde)로서 얻어진 MDA 표준곡선으로부터 nmole로 나타내었다.Oxidation of LDL was assessed by the amount of thiobarbitureic acid reacting substances (TBARS) formed. 1.5 ml of 20% TCA (Trichloroacetic acid) was added to 100 µl of the culture mixture for each concentration containing 10 µl of LDL (100 µg protein / mL), followed by mixing 2 ml of 0.05M NaOH and 0.67% TBA (Thiobarbituric acid). After heating at 90 ℃ for 45 minutes. After centrifugation (2,000Xg) for 10 minutes, the supernatant was measured at 510 and 553nm with a Perkin-Elmer fluorescence photometer (Model 650-10S USA). The number of TBARS in the sample is expressed in nmole from the MDA standard curve obtained as MDA (malondialdehyde).
그 결과의 평균치를 표 10에 나타내었다. 생식조성물을 처리한 군의 TBARS 값은 투여량에 비례하여 감소하는 결과를 보이므로 생식조성물의 항산화 기능이 유효성있게 나타남을 확인할 수 있었다.The average value of the result is shown in Table 10. The TBARS value of the reproductive composition decreased in proportion to the dose, indicating that the antioxidant function of the reproductive composition was effective.
시험예 5: 혈중 지질과산화물 생성 영향Test Example 5: Effect of Lipid Peroxide Formation in Blood
상기 실시예 3의 생식조성물을 4주간 매일 1회에 20g씩 2회 복용시켰다. 복용전(대조군)과 복용후에 조사대상으로부터 혈액을 10㎖씩 채혈하고 원심분리하여 혈청을 분리하였다. 상기 혈청을 이용하여 활성산소 소거활성의 지표인 혈중 지질과산화물을 측정하였다. 혈중 과산화물은 지방과산화 어세이 키트(Lipid peroxydation assay kit)를 사용하여 과산화되어 생성된 MDA를 발색시켜 분광광도계로 586nm에서 측정하였다. 표 11에서 "기존 항산화제 조성물"의 혈중 지질과산화물생성 영향은 대한민국 특허공보 제2003-0015347호에 명시된 데이터를 본 발명의 생식조성물과 비교하기 위하여 인용하였다.The reproductive composition of Example 3 was taken twice by 20g once daily for four weeks. Serum was isolated by taking 10 ml of blood from the subjects before and after the administration (control group) and after the administration. The serum was used to measure lipid peroxides indices of free radical scavenging activity. Blood peroxide was measured at 586 nm with a spectrophotometer by developing MDA produced by peroxidation using a lipid peroxydation assay kit. In Table 11 the blood lipid peroxide production effects of the "existing antioxidant composition" were cited to compare the data specified in Korean Patent Publication No. 2003-0015347 with the reproductive composition of the present invention.
상기 결과 기존 생약조성물과 비교하여 생식조성물의 항산화능이 유사하게 나타났다.As a result, the antioxidant activity of the reproductive composition was similar to the conventional herbal composition.
따라서, 본 발명은 생식제품에 식품효소를 이용하여 난소화성을 향상시키고, 영양요구성이 풍부한 생식조성물을 제공할 수 있다.Therefore, the present invention can improve the indigestibility by using food enzymes in the reproductive product, it is possible to provide a reproductive composition rich in nutritional composition.
또한, 본 발명은 크릴새우 엑스 등을 첨가하여 항산화 기능을 갖는 생식조성물을 제공할 수 있다.In addition, the present invention can be added to krill shrimp X and the like to provide a reproductive composition having an antioxidant function.
또한, 본 발명은 용해도가 향상되어 물에 풀어 먹기 좋은 생식조성물을 제공한다.In addition, the present invention provides a reproductive composition that is easy to dissolve in water solubility is improved.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030036857 | 2003-06-09 | ||
KR20030036857 | 2003-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040106900A KR20040106900A (en) | 2004-12-18 |
KR100541719B1 true KR100541719B1 (en) | 2006-01-10 |
Family
ID=37381210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030054522A KR100541719B1 (en) | 2003-06-09 | 2003-08-07 | A raw-food composition improved the digestion and antioxidation |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100541719B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885293A (en) * | 2011-07-18 | 2013-01-23 | 青贵军 | Spirulina health food and preparation method |
KR101547133B1 (en) | 2013-11-19 | 2015-08-25 | 재단법인 경북바이오산업연구원 | Cereals powder compounds |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100653901B1 (en) * | 2005-05-25 | 2006-12-06 | 김경태 | Rice formed by fiber not having dissociation |
KR100845032B1 (en) * | 2006-12-13 | 2008-07-09 | 주식회사농심 | Rice peptide containing antioxidant activity and radical scavenging activity and the method thereof |
WO2008115583A1 (en) * | 2007-03-21 | 2008-09-25 | John Mini | Herbal treatments |
KR100856835B1 (en) * | 2007-05-29 | 2008-09-05 | 주식회사 보양 | Composition for nutritional improvement using seamustard stem and seamustard sporophyll |
KR101135290B1 (en) * | 2009-09-29 | 2012-04-12 | 웅진식품주식회사 | A composition of health food containing enzymes, trehalose, extract of gardeniae fructus based on probiotics with colon health and improved digestion features |
KR101338929B1 (en) * | 2011-12-09 | 2013-12-10 | 최안순 | A foodstuff supplement containing fermented cereals-enzyme |
CN103262983B (en) * | 2013-06-18 | 2015-07-29 | 云南普瑞生物制药有限公司 | A kind of processing technology of slaking lotus-seed-heart powder |
KR101713176B1 (en) | 2015-10-12 | 2017-03-07 | 전남대학교산학협력단 | Fermented medicinal-herb composition having antioxidation activity and and method for preparing thereof |
KR20210085294A (en) | 2019-12-30 | 2021-07-08 | 강원대학교산학협력단 | Anti oxidative, anti inflammatory and healthy gastric raw food composition |
-
2003
- 2003-08-07 KR KR1020030054522A patent/KR100541719B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885293A (en) * | 2011-07-18 | 2013-01-23 | 青贵军 | Spirulina health food and preparation method |
KR101547133B1 (en) | 2013-11-19 | 2015-08-25 | 재단법인 경북바이오산업연구원 | Cereals powder compounds |
Also Published As
Publication number | Publication date |
---|---|
KR20040106900A (en) | 2004-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Svanberg et al. | Fermentation and nutrient availability | |
US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
KR102118697B1 (en) | Manufacturing method of sprout barley juice powder and sprout barley juice powder mixing compound therof | |
KR101594490B1 (en) | Method for Manufacturing Fermented Sea Cucumber, and Fermented Sea Cucumber Produced Thereby | |
JP4653655B2 (en) | Method for producing fermented food | |
KR100541719B1 (en) | A raw-food composition improved the digestion and antioxidation | |
US20210046003A1 (en) | Health drink composition for preventing liver damage caused by alcohol while providing excellent hangover relief | |
EP3238548B1 (en) | Method for producing raw pills of fermented minerals having functions of improving constipation and recovery from fatigue, and raw pills of fermented minerals produced thereby | |
Jeyakumar et al. | Microbial fermentation for reduction of antinutritional factors | |
KR20120110956A (en) | Precess of enzyme health food having high activity bymicrobial fermentation | |
KR20190091053A (en) | Chomposition for preventing alcohol hangover containing aminoacid-enriched product and method for manufacturing thereof | |
KR20160055292A (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR101592938B1 (en) | Anti-obesity health functional fermented soybean beverage having flavored taste | |
CN116098284A (en) | Composite ferment and preparation method thereof | |
Astuti | Health benefits of tempe | |
CN115211510A (en) | A health beverage for removing dampness and oil and its preparation method | |
JP2000256394A (en) | Production of physiologically active peptide composition | |
JP2002101816A (en) | Method for producing kimchi | |
JP2006006156A (en) | Liver function-enhancing health food | |
KR20210060911A (en) | Manufacturing method of soymilk | |
Kiers | Effects of fermented soya bean on digestion, absorption and diarrhoea | |
Ayyadurai et al. | Beneficial role of fermented rice in healthy lifestyle | |
KR100623280B1 (en) | A preparing method of fermented-diet drink containing Saliconia herbacea L. extract | |
RU2790676C1 (en) | Plant-based probiotic composition and method for its obtaining | |
Saibhavani et al. | Chapter-7 role of traditional foods for immunity boosting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |